Tamara Grodzicky

2.6k total citations · 1 hit paper
17 papers, 1.7k citations indexed

About

Tamara Grodzicky is a scholar working on Rheumatology, Pathology and Forensic Medicine and Molecular Biology. According to data from OpenAlex, Tamara Grodzicky has authored 17 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Rheumatology, 6 papers in Pathology and Forensic Medicine and 4 papers in Molecular Biology. Recurrent topics in Tamara Grodzicky's work include Systemic Lupus Erythematosus Research (7 papers), Systemic Sclerosis and Related Diseases (6 papers) and Inflammatory Myopathies and Dermatomyositis (4 papers). Tamara Grodzicky is often cited by papers focused on Systemic Lupus Erythematosus Research (7 papers), Systemic Sclerosis and Related Diseases (6 papers) and Inflammatory Myopathies and Dermatomyositis (4 papers). Tamara Grodzicky collaborates with scholars based in Canada, United States and United Kingdom. Tamara Grodzicky's co-authors include Michał Abrahamowicz, Paul R. Fortin, Ann E. Clarke, Yin Li, Steven A. Grover, Roxane du Berger, Yves Raymond, Jean‐Richard Goulet, Martial Koenig and Éric Rich and has published in prestigious journals such as The American Journal of Medicine, Journal of Cellular Physiology and The Journal of Pathology.

In The Last Decade

Tamara Grodzicky

17 papers receiving 1.7k citations

Hit Papers

Traditional Framingham risk factors fail to fully account... 2001 2026 2009 2017 2001 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tamara Grodzicky Canada 13 1.0k 883 603 255 236 17 1.7k
Alfonso Corrales Spain 25 1.1k 1.0× 554 0.6× 204 0.3× 206 0.8× 199 0.8× 90 1.9k
Edit Bodolay Hungary 19 477 0.5× 320 0.4× 462 0.8× 196 0.8× 60 0.3× 37 1.2k
G Tirri Italy 16 431 0.4× 265 0.3× 747 1.2× 254 1.0× 258 1.1× 44 1.3k
Szilvia Szamosi Hungary 20 386 0.4× 286 0.3× 338 0.6× 158 0.6× 117 0.5× 58 1.0k
Karina de Leeuw Netherlands 20 651 0.6× 627 0.7× 172 0.3× 97 0.4× 57 0.2× 64 1.4k
J S Smolen Austria 22 1.3k 1.2× 614 0.7× 213 0.4× 81 0.3× 75 0.3× 39 1.8k
P. Nicaise‐Roland France 24 931 0.9× 396 0.4× 166 0.3× 109 0.4× 105 0.4× 56 1.5k
Floranne C. Ernste United States 21 810 0.8× 390 0.4× 186 0.3× 587 2.3× 140 0.6× 50 1.4k
Ugo Fiocco Italy 24 969 0.9× 493 0.6× 184 0.3× 118 0.5× 77 0.3× 57 1.5k
Serena Bugatti Italy 28 1.3k 1.2× 655 0.7× 164 0.3× 102 0.4× 102 0.4× 89 2.1k

Countries citing papers authored by Tamara Grodzicky

Since Specialization
Citations

This map shows the geographic impact of Tamara Grodzicky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tamara Grodzicky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tamara Grodzicky more than expected).

Fields of papers citing papers by Tamara Grodzicky

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tamara Grodzicky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tamara Grodzicky. The network helps show where Tamara Grodzicky may publish in the future.

Co-authorship network of co-authors of Tamara Grodzicky

This figure shows the co-authorship network connecting the top 25 collaborators of Tamara Grodzicky. A scholar is included among the top collaborators of Tamara Grodzicky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tamara Grodzicky. Tamara Grodzicky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Chin, Anne S., Jean Chalaoui, Yves Provost, et al.. (2016). Imaging of Systemic Sclerosis (Scleroderma). Contemporary Diagnostic Radiology. 39(6). 1–7. 1 indexed citations
2.
Troyanov, Yves, Ira N. Targoff, Jean‐Pierre Raynauld, et al.. (2014). Redefining Dermatomyositis. Medicine. 93(24). 318–332. 56 indexed citations
4.
Chabaud, Stéphane, Tamara Grodzicky, Jean‐Luc Senécal, et al.. (2010). Decreased secretion of MMP by non-lesional late-stage scleroderma fibroblasts after selection via activation of the apoptotic fas-pathway. Journal of Cellular Physiology. 226(7). 1907–1914. 15 indexed citations
5.
Boufaied, Inès, Julie Lessard, Stéphane Chabaud, et al.. (2008). The fibrotic phenotype of systemic sclerosis fibroblasts varies with disease duration and severity of skin involvement: reconstitution of skin fibrosis development using a tissue engineering approach. The Journal of Pathology. 217(4). 534–542. 38 indexed citations
7.
Panopalis, Pantelis, Michelle Petri, Susan Manzi, et al.. (2007). The systemic lupus erythematosus Tri‐Nation study: Cumulative indirect costs. Arthritis Care & Research. 57(1). 64–70. 52 indexed citations
8.
Panopalis, Peter, Michelle Petri, S Manzi, et al.. (2005). The systemic lupus erythematosus tri-nation study: longitudinal changes in physical and mental well-being. Lara D. Veeken. 44(6). 751–755. 38 indexed citations
9.
Grodzicky, Tamara, James B. Bussel, & Keith B. Elkon. (2002). Anti-platelet antibodies associated with the Canale–Smith syndrome bind to the same platelet glycoprotein complexes as those of idiopathic thrombocytopenic purpura patients. Clinical & Experimental Immunology. 127(2). 289–292. 9 indexed citations
10.
Grodzicky, Tamara & Keith B. Elkon. (2002). Apoptosis: a case where too much or too little can lead to autoimmunity.. PubMed. 69(4). 208–19. 17 indexed citations
11.
Abrahamowicz, Michał, Tamara Grodzicky, Yin Li, et al.. (2001). Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. Arthritis & Rheumatism. 44(10). 2331–2337. 908 indexed citations breakdown →
12.
Moore, Andrew, Susan Manzi, David Isenberg, et al.. (2000). The use of alternative medical therapies in patients with systemic lupus erythematosus. Arthritis & Rheumatism. 43(6). 1410–1418. 51 indexed citations
13.
Grodzicky, Tamara & Keith B. Elkon. (2000). Apoptosis in rheumatic diseases. The American Journal of Medicine. 108(1). 73–82. 28 indexed citations
14.
Clarke, A., S Manzi, David Isenberg, et al.. (1999). An international perspective on the well being and health care costs for patients with systemic lupus erythematosus. Tri-Nation Study Group.. PubMed. 26(7). 1500–11. 51 indexed citations
15.
Vázquez‐Abad, Dolores, Tamara Grodzicky, & Jean‐Luc Senécal. (1999). Anticentromere Autoantibodies in Patients without Raynaud's Disease or Systemic Sclerosis. Clinical Immunology. 90(2). 182–189. 7 indexed citations
16.
Grodzicky, Tamara, R G Lahita, R Comtois, & J Sénécal. (1999). Severe mixed connective tissue disease in a woman with pure gonadal dysgenesis: estrogens do not influence disease expression.. PubMed. 26(4). 923–6. 1 indexed citations
17.
Senécal, Jean‐Luc, Joyce Rauch, Tamara Grodzicky, et al.. (1999). Strong association of autoantibodies to human nuclear lamin B1 with lupus anticoagulant antibodies in systemic lupus erythematosus. Arthritis & Rheumatism. 42(7). 1347–1353. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026